ACADIA Pharmaceuticals
ACAD
#4034
Rank
A$4.46 B
Marketcap
A$25.85
Share price
-2.73%
Change (1 day)
-29.14%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): A$3.15

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$3.22. In 2025 the company made an earnings per share (EPS) of A$3.51 an increase over its 2024 EPS that were of A$2.05.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.15-10.01%
2025A$3.5170.59%
2024A$2.05-457.89%
2023A-$0.57-71.64%
2022A-$2.0227.62%
2021A-$1.59-41.67%
2020A-$2.7212.5%
2019A-$2.42-17.95%
2018A-$2.95-17.02%
2017A-$3.550.43%
2016A-$3.5443.56%
2015A-$2.4673.4%
2014A-$1.42
2012A-$0.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.07-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.67 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.83 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
A-$6.98-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA